Incidental Mutation 'R6020:Irak3'
ID 478874
Institutional Source Beutler Lab
Gene Symbol Irak3
Ensembl Gene ENSMUSG00000020227
Gene Name interleukin-1 receptor-associated kinase 3
Synonyms IRAK-M, 4833428C18Rik
Accession Numbers
Essential gene? Possibly essential (E-score: 0.530) question?
Stock # R6020 (G1)
Quality Score 225.009
Status Not validated
Chromosome 10
Chromosomal Location 119977553-120038035 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 119979042 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Proline to Threonine at position 470 (P470T)
Ref Sequence ENSEMBL: ENSMUSP00000020448 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000020448] [ENSMUST00000135106] [ENSMUST00000145665]
AlphaFold Q8K4B2
Predicted Effect probably damaging
Transcript: ENSMUST00000020448
AA Change: P470T

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000020448
Gene: ENSMUSG00000020227
AA Change: P470T

DomainStartEndE-ValueType
Pfam:Death 26 106 1.3e-15 PFAM
Pfam:Pkinase 178 456 8.4e-37 PFAM
Pfam:Pkinase_Tyr 178 456 2e-35 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000135106
SMART Domains Protein: ENSMUSP00000123604
Gene: ENSMUSG00000020227

DomainStartEndE-ValueType
Pfam:Death 26 106 2.2e-16 PFAM
Pfam:Pkinase_Tyr 178 301 3.1e-15 PFAM
Pfam:Pkinase 178 302 4.9e-18 PFAM
Predicted Effect possibly damaging
Transcript: ENSMUST00000145665
AA Change: P378T

PolyPhen 2 Score 0.805 (Sensitivity: 0.84; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000118038
Gene: ENSMUSG00000020227
AA Change: P378T

DomainStartEndE-ValueType
Pfam:Pkinase 86 364 8.4e-35 PFAM
Pfam:Pkinase_Tyr 86 364 1.7e-34 PFAM
Coding Region Coverage
  • 1x: 99.9%
  • 3x: 99.6%
  • 10x: 97.8%
  • 20x: 93.4%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the interleukin-1 receptor-associated kinase protein family. Members of this family are essential components of the Toll/IL-R immune signal transduction pathways. This protein is primarily expressed in monocytes and macrophages and functions as a negative regulator of Toll-like receptor signaling. Mutations in this gene are associated with a susceptibility to asthma. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
PHENOTYPE: Mice homozygous for disruptions in this gene display abnormal inflammatory responses to bacterial infections and loose bone mass with age. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 76 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca9 C A 11: 110,036,439 (GRCm39) V557F possibly damaging Het
Abi3 A T 11: 95,732,851 (GRCm39) L41* probably null Het
Actn1 C A 12: 80,221,229 (GRCm39) probably null Het
Adamts15 G T 9: 30,813,358 (GRCm39) R936S probably benign Het
Angel2 T C 1: 190,665,068 (GRCm39) S22P probably benign Het
Ank2 T G 3: 126,740,470 (GRCm39) probably benign Het
Astn1 A G 1: 158,337,563 (GRCm39) D423G probably damaging Het
Casp9 A G 4: 141,523,849 (GRCm39) D78G probably damaging Het
Cbr4 A G 8: 61,940,887 (GRCm39) D2G probably benign Het
Ccdc8 T A 7: 16,730,506 (GRCm39) L665H probably damaging Het
Cdh23 T A 10: 60,167,105 (GRCm39) N1847I probably damaging Het
Cnst T C 1: 179,437,440 (GRCm39) W335R probably benign Het
Ddr2 T A 1: 169,832,671 (GRCm39) I130F probably benign Het
Dnah2 C T 11: 69,391,665 (GRCm39) A677T probably benign Het
Dzip3 C A 16: 48,772,205 (GRCm39) W488L probably damaging Het
Ephb3 T G 16: 21,040,763 (GRCm39) I637S probably damaging Het
Etv3 A G 3: 87,436,671 (GRCm39) D142G probably benign Het
Fabp5 C T 3: 10,081,149 (GRCm39) T126I probably benign Het
Fam13b A C 18: 34,627,827 (GRCm39) Y125D probably damaging Het
Fsip2 C A 2: 82,822,471 (GRCm39) P6068Q probably damaging Het
Gm11232 A G 4: 71,674,905 (GRCm39) F199S possibly damaging Het
Gm5493 A G 17: 22,967,034 (GRCm39) K57E probably benign Het
Gm7334 A G 17: 51,006,265 (GRCm39) M184V probably benign Het
Gm9894 T C 13: 67,911,954 (GRCm39) noncoding transcript Het
Gpd2 T A 2: 57,254,525 (GRCm39) N674K probably benign Het
H2-M10.6 A G 17: 37,123,959 (GRCm39) Y141C probably damaging Het
Heatr5a C T 12: 51,931,110 (GRCm39) E1796K probably benign Het
Hexim2 A G 11: 103,029,118 (GRCm39) T57A probably benign Het
Hrg A T 16: 22,773,268 (GRCm39) N134Y probably damaging Het
Hsd17b12 T C 2: 93,864,322 (GRCm39) T262A probably damaging Het
Itgbl1 A T 14: 124,083,977 (GRCm39) D285V probably damaging Het
Kcp A T 6: 29,502,863 (GRCm39) V164E probably benign Het
Klhdc7b T A 15: 89,272,589 (GRCm39) M1157K probably damaging Het
Lcor G A 19: 41,571,986 (GRCm39) G247D possibly damaging Het
Mdc1 G A 17: 36,159,525 (GRCm39) G635D probably benign Het
Mdc1 A G 17: 36,168,464 (GRCm39) K1690R probably benign Het
Mpp3 A T 11: 101,909,365 (GRCm39) probably benign Het
Ncor2 G T 5: 125,097,075 (GRCm39) H2285N probably benign Het
Neb T A 2: 52,147,839 (GRCm39) T2727S probably benign Het
Nkx6-2 T C 7: 139,161,483 (GRCm39) D234G possibly damaging Het
Nlrp9c T C 7: 26,084,150 (GRCm39) I476M probably benign Het
Nrsn1 T G 13: 25,437,355 (GRCm39) Q191P probably damaging Het
Or14j10 A T 17: 37,934,858 (GRCm39) S223T possibly damaging Het
Or1e30 C T 11: 73,678,378 (GRCm39) L205F probably benign Het
Or51ag1 T A 7: 103,156,006 (GRCm39) H49L probably benign Het
Patl1 T G 19: 11,914,718 (GRCm39) L623R probably damaging Het
Pdc T C 1: 150,209,117 (GRCm39) I200T probably benign Het
Pdzk1 A G 3: 96,775,742 (GRCm39) D370G probably benign Het
Pglyrp3 A T 3: 91,938,841 (GRCm39) I339F probably damaging Het
Plxnb1 T C 9: 108,945,679 (GRCm39) V2070A probably damaging Het
Poln G A 5: 34,266,775 (GRCm39) R461C probably damaging Het
Prl2b1 C A 13: 27,567,491 (GRCm39) V218L probably damaging Het
Pygl T C 12: 70,263,428 (GRCm39) D55G probably damaging Het
Rif1 C G 2: 51,985,856 (GRCm39) L614V probably damaging Het
Rnd2 C T 11: 101,359,825 (GRCm39) L57F probably damaging Het
Rsrp1 T C 4: 134,651,692 (GRCm39) F152S probably damaging Het
Sim2 T C 16: 93,898,110 (GRCm39) S115P probably damaging Het
Slc17a1 T A 13: 24,059,593 (GRCm39) I108K possibly damaging Het
Slc30a8 A G 15: 52,189,054 (GRCm39) D223G probably damaging Het
Slc39a4 A T 15: 76,500,342 (GRCm39) N69K probably benign Het
Slc51a T G 16: 32,298,584 (GRCm39) T58P probably damaging Het
Slc7a14 T C 3: 31,278,261 (GRCm39) H448R probably benign Het
Smc3 G A 19: 53,613,594 (GRCm39) probably null Het
Sox6 A T 7: 115,085,863 (GRCm39) D659E probably damaging Het
Stard9 GCCC GCC 2: 120,524,196 (GRCm39) probably null Het
Tsr1 C T 11: 74,791,119 (GRCm39) probably null Het
Ttc12 T C 9: 49,354,422 (GRCm39) K565E probably damaging Het
Ube4b A T 4: 149,452,768 (GRCm39) V386E probably benign Het
Ush2a T A 1: 188,460,293 (GRCm39) probably null Het
Usp5 C A 6: 124,794,576 (GRCm39) probably benign Het
Vmn1r216 T C 13: 23,284,105 (GRCm39) F263L probably benign Het
Vmn2r88 T A 14: 51,655,606 (GRCm39) L606* probably null Het
Wee2 T A 6: 40,426,554 (GRCm39) probably null Het
Zfhx3 T C 8: 109,519,159 (GRCm39) Y94H probably damaging Het
Zfp385c G A 11: 100,523,594 (GRCm39) P120L probably benign Het
Zscan4-ps3 T C 7: 11,344,228 (GRCm39) F62S probably damaging Het
Other mutations in Irak3
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00332:Irak3 APN 10 120,013,972 (GRCm39) critical splice donor site probably null
IGL01015:Irak3 APN 10 119,978,695 (GRCm39) nonsense probably null
IGL01530:Irak3 APN 10 119,978,699 (GRCm39) missense probably benign 0.10
IGL01641:Irak3 APN 10 120,012,252 (GRCm39) missense probably benign 0.35
IGL01730:Irak3 APN 10 120,014,005 (GRCm39) missense probably benign 0.04
IGL02054:Irak3 APN 10 120,012,164 (GRCm39) missense probably benign 0.01
IGL02938:Irak3 APN 10 120,018,429 (GRCm39) critical splice donor site probably null
IGL02954:Irak3 APN 10 120,012,147 (GRCm39) missense probably damaging 0.98
IGL02992:Irak3 APN 10 120,018,566 (GRCm39) missense probably damaging 1.00
IGL03376:Irak3 APN 10 119,982,541 (GRCm39) splice site probably benign
iracema UTSW 10 119,981,687 (GRCm39) missense probably damaging 0.99
R0031:Irak3 UTSW 10 120,012,225 (GRCm39) nonsense probably null
R0734:Irak3 UTSW 10 119,981,542 (GRCm39) splice site probably benign
R1017:Irak3 UTSW 10 119,978,789 (GRCm39) missense possibly damaging 0.94
R1025:Irak3 UTSW 10 120,012,251 (GRCm39) missense probably damaging 1.00
R1486:Irak3 UTSW 10 119,978,966 (GRCm39) missense probably damaging 1.00
R1538:Irak3 UTSW 10 120,001,035 (GRCm39) missense probably benign 0.00
R1596:Irak3 UTSW 10 120,018,451 (GRCm39) missense probably damaging 1.00
R1689:Irak3 UTSW 10 119,982,457 (GRCm39) missense probably damaging 0.98
R2133:Irak3 UTSW 10 120,001,082 (GRCm39) missense probably benign 0.10
R3609:Irak3 UTSW 10 119,981,582 (GRCm39) missense possibly damaging 0.95
R3947:Irak3 UTSW 10 120,006,278 (GRCm39) missense probably benign 0.00
R3948:Irak3 UTSW 10 120,006,278 (GRCm39) missense probably benign 0.00
R4510:Irak3 UTSW 10 119,981,813 (GRCm39) missense probably damaging 0.99
R4511:Irak3 UTSW 10 119,981,813 (GRCm39) missense probably damaging 0.99
R4885:Irak3 UTSW 10 120,018,586 (GRCm39) missense probably damaging 1.00
R5007:Irak3 UTSW 10 119,982,334 (GRCm39) critical splice donor site probably null
R5180:Irak3 UTSW 10 119,981,687 (GRCm39) missense probably damaging 0.99
R5704:Irak3 UTSW 10 119,981,594 (GRCm39) missense probably benign 0.04
R5715:Irak3 UTSW 10 119,978,641 (GRCm39) missense possibly damaging 0.66
R6916:Irak3 UTSW 10 120,037,270 (GRCm39) missense probably damaging 1.00
R7182:Irak3 UTSW 10 120,002,416 (GRCm39) missense probably damaging 1.00
R7707:Irak3 UTSW 10 119,982,489 (GRCm39) missense probably damaging 0.99
R7787:Irak3 UTSW 10 120,012,256 (GRCm39) missense probably benign 0.06
R8087:Irak3 UTSW 10 120,018,440 (GRCm39) missense probably benign 0.02
R8673:Irak3 UTSW 10 119,982,493 (GRCm39) missense possibly damaging 0.68
X0023:Irak3 UTSW 10 119,979,092 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- AGACTGGCTGCATTCAAAGGG -3'
(R):5'- CTCTCGGAATAAAGGGGCTTC -3'

Sequencing Primer
(F):5'- CATTCAAAGGGGGTTTTCTGAGTCAC -3'
(R):5'- CGGAATAAAGGGGCTTCTCCAATATC -3'
Posted On 2017-06-26